Table 1 Clinical details and HPV analysis of the 12 adenocarcinomas in the study
From: Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
Follow-up | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Case no. | Cancer diagnosis | Last Pap smear year/ result | Age at diagnosis (years) | Tumour stage | Tumour differentiation | Lymph node involvement | HPV infection | Time (years) | Outcome |
1 | 1992 | 1990/normal | 30 | 1B | Poor | No | HPV 16 | 13 | AwoD |
2 | 1992 | 1989/normal | 46 | 1B | Poor | No | HPV 18 | 13 | AwoD |
3 | 1995 | 1992/normal | 37 | 1B | Well | No | HPV 18 | 10 | AwoD |
4 | 1997 | 1987/normal | 39 | 1B | Well | No | Not detected | 8 | AwoD |
5 | 1992 | 1978/normal | 50 | 2B | Well | Yes | Not detected | 13 | AwoD |
6 | 1994 | 1992/normal | 32 | 1B | Poor | No | HPV 18 | 11 | AwoD |
7 | 2000 | 1997/normal | 62 | 1B | Well | No | HPV 45 | 4 | DoD |
8 | 2000 | 1998/normal | 64 | 1B | Poor | No | Not detected | 5 | AwoD |
9 | 1999 | 1996/normal | 63 | 2B | Moderate | Yes | Not detected | 6 | AwoD |
10 | 2000 | 1999/inflammation | 53 | 1A | Well | No | HPV 16 | 5 | AwoD |
11 | 1997 | 1996/normal | 45 | 1B | Well | No | HPV 18 | 7 | DoD |
12 | 1993 | 1992/normal | 49 | 1A | Well | No | HPV 18 | 11 | AwoD |
